Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
Varettoni M, Zibellini S, Boveri E, Klersy C, Candido C, Rattotti S, Ferretti VV, Defrancesco I, Mangiacavalli S, Nizzoli ME, Flospergher E, Zerbi C, Bergamini F, Benvenuti P, Brociner M, Merati G, Paulli M, Arcaini L. Varettoni M, et al. Among authors: flospergher e. Br J Haematol. 2019 Nov;187(4):441-446. doi: 10.1111/bjh.16086. Epub 2019 Jul 5. Br J Haematol. 2019. PMID: 31276195 Free article.
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
Rattotti S, Ferretti VV, Rusconi C, Rossi A, Fogazzi S, Baldini L, Pioltelli P, Balzarotti M, Farina L, Ferreri AJM, Laszlo D, Speziale V, Varettoni M, Sciarra R, Morello L, Tedeschi A, Frigeni M, Defrancesco I, Zerbi C, Flospergher E, Nizzoli ME, Morra E, Arcaini L; “Rete Ematologica Lombarda” (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup). Rattotti S, et al. Among authors: flospergher e. Hematol Oncol. 2019 Apr;37(2):160-167. doi: 10.1002/hon.2575. Epub 2019 Feb 22. Hematol Oncol. 2019. PMID: 30726562 Clinical Trial.
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia.
Corbingi A, Innocenti I, Tomasso A, Pasquale R, Visentin A, Varettoni M, Flospergher E, Autore F, Morelli F, Trentin L, Reda G, Efremov DG, Laurenti L. Corbingi A, et al. Among authors: flospergher e. Br J Haematol. 2020 Sep;190(6):901-908. doi: 10.1111/bjh.16975. Epub 2020 Jul 26. Br J Haematol. 2020. PMID: 32712965 Free article. Clinical Trial.
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis.
Defrancesco I, Zibellini S, Boveri E, Frigeni M, Ferretti VV, Rizzo E, Bonometti A, Capuano F, Candido C, Rattotti S, Tenore A, Picone C, Flospergher E, Zerbi C, Bergamini F, Fabbri N, Cristinelli C, Varettoni M, Paulli M, Arcaini L. Defrancesco I, et al. Among authors: flospergher e. Hematol Oncol. 2020 Dec;38(5):689-697. doi: 10.1002/hon.2784. Epub 2020 Aug 19. Hematol Oncol. 2020. PMID: 32738175
Prognostic impact of somatic mutations on time to first treatment: Results of targeted next-generation sequencing in 211 patients with early stage chronic lymphocytic leukemia.
Varettoni M, Orlandi E, Zibellini S, Rossi M, Gentile M, Flospergher E, Ferretti VV, Rizzo E, Della Porta MG, Rattotti S, Cavalloni C, Bergamini F, Cristinelli C, Fabbri N, Gallì A, Arcaini L. Varettoni M, et al. Among authors: flospergher e. Am J Hematol. 2021 Nov 1;96(11):E404-E408. doi: 10.1002/ajh.26302. Epub 2021 Aug 11. Am J Hematol. 2021. PMID: 34329489 Free article. No abstract available.
Primary central nervous system marginal zone lymphoma.
Flospergher E, Marino F, Calimeri T, Cangi MG, Ferreri AJM, Ponzoni M, Bongiovanni L. Flospergher E, et al. Br J Haematol. 2024 Jan;204(1):31-44. doi: 10.1111/bjh.19238. Epub 2023 Dec 6. Br J Haematol. 2024. PMID: 38054330 Review.
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
Ferreri AJM, Angelillo P, Erbella F, Cattaneo C, Verga L, Lleshi A, Allione B, Ponzoni M, Facchetti F, Pagani C, Foppoli M, Pecciarini L, Sassone M, Steffanoni S, Flospergher E, Rossi G, Spina M, Re A. Ferreri AJM, et al. Among authors: flospergher e. Blood Adv. 2022 Nov 22;6(22):5811-5820. doi: 10.1182/bloodadvances.2022007475. Blood Adv. 2022. PMID: 35580327 Free PMC article.